Cardiovascular aging is increasingly recognized as the result of a dynamic interplay between the vascular and immune systems rather than passive “wear and tear.” With advancing age, endothelial cells lose their capacity to maintain vascular tone, barrier integrity, and antithrombotic function, while smooth muscle cells and the extracellular matrix remodel in ways that promote stiffness and impaired tissue perfusion. In parallel, the immune system drifts toward chronic, low‑grade inflammation (“inflammaging”), marked by dysregulated innate and adaptive responses, immune cell senescence, and altered cytokine and chemokine networks. This state fuels endothelial activation, oxidative stress, and maladaptive repair, thereby accelerating atherosclerosis, microvascular dysfunction, heart failure, and other age‑related cardiovascular syndromes. Emerging evidence implicates clonal hematopoiesis, trained immunity, and shifts in myeloid and lymphoid cell populations as direct modulators of vascular phenotype in aging. However, the underlying mechanisms and the identification of robust, clinically useful biomarkers that capture this vascular–immune axis remain incomplete.

This Research Topic aims to elucidate how vascular–immune crosstalk drives cardiovascular aging and to highlight novel biomarkers and therapeutic entry points along this axis. We welcome original research, reviews, mini‑reviews, and perspectives spanning basic, translational, and clinical science.

This collection welcomes contributions in the following areas, among others:

Cellular and molecular pathways governing vascular–immune interactions in aging (e.g., endothelial activation, senescence, clonal hematopoiesis, trained immunity).

Contributions of specific immune cell subsets (macrophages, T cells, B cells, NK cells, neutrophils, innate lymphoid cells) to vascular aging, arterial stiffness, and microvascular rarefaction.

Novel circulating and tissue biomarkers (proteomic, transcriptomic, metabolomic, epigenetic, extracellular vesicle‑based) that reflect vascular–immune dysregulation in older individuals.

Imaging and functional biomarkers (e.g., vascular ultrasound, PET/MRI, flow‑mediated dilation, pulse wave velocity) integrated with immune and inflammatory signatures.

Sex, metabolic, and environmental modifiers (e.g., obesity, diabetes, pollution, diet, physical activity) shaping vascular–immune interactions across the lifespan.

Translational and interventional studies targeting vascular–immune pathways (pharmacologic, biologic, lifestyle, or geroscience‑guided strategies) to prevent, delay, or reverse cardiovascular aging.

Are you interested in contributing a manuscript to this Research Topic?

Vascular-Immune Interactions in Cardiovascular Aging: Novel Mechanisms and Biomarkers